Email this article Morphologic diagnostics of prostate ductal adenocarcinoma
- Authors: Poletaeva SV1, Poletaeva SV1
-
Affiliations:
- Самарский государственный медицинский университет
- Issue: Vol 13, No 1-2 (2013)
- Pages: 205-209
- Section: Articles
- URL: https://ogarev-online.ru/2410-3764/article/view/24807
- DOI: https://doi.org/10.17816/2072-2354.2013.0.1-2.205-209
- ID: 24807
Cite item
Full Text
Abstract
The morphologic features of tumors in patients with locally confined or advanced prostate ductal adenocarcinoma who had undergone radical prostatectomy were evaluated. Volumes of prostate gland, volumes of tumors, Gleason scores, pathologic stages, PSA levels were examined. We identified patients who had histologically pure ductal adenocarcinoma (18%), predominantly ductal adenocarcinoma (32%), whereas the other 50% had mixed ductal and acinar prostate cancer. 15 patients of the mixed pathology group also had evidence of neuroendocrine, sarcomatoid, mucinus or squamous differentiation. Differential diagnosis must exclude high grade prostatic intraepithelial neoplasia, non-ductal intraductal adenocarcinoma, cribriform acinar adenocarcinoma.
Full Text
##article.viewOnOriginalSite##References
- Amin M., Boccon-Gibod L., Egevad L. et al. Prognostic and predictiv factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol 2005; 216: p.20-33.
- Boccon-Gibod L., van der Kwast T.H., Montironi R. et al. European Society of Uropathology; European Society of Pathology Uropatholog aWorking Group. Handling and pathology reporting of prostate biopsies. Eur. Urol. 2004; 46: p.177-81.
- Montironi R., Vela-Navarrete R., Lopez-Beltran A. 2005 update on pathology of prostate biopsies with cancer. Eur Urol 2006; 49: p.241-7.
- Humphrey, P. A. Histological variants of prostatic carcinoma and their significance. Histopathology,2012; 60: p.59–74.
- Sathesan B., Goonewardena A.S., Anuruddhika et al. Ductal adencarcinoma of the prostate. A clinicopathological study. Sri Lanka Journal of Urology, 2008; 9, p.20-24.
- Kelemen K., Adley B., Yang X.J., Wang H.L., Humphrey P.A. Ductal adencarcinoma of the prostate. A clinicopathological study of 50 cases. Lab. Invest. 2006; 86: p.144.
- Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL. Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol. 2010 Dec;184(6): p.2303-7.
- Robinson B, Magi-Galluzzi C, Zhou M. Intraductal carcinoma of the prostate. Arch Pathol Lab Med. 2012 Apr;136(4): p.418-25.
- Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol. 2006; Dec;19(12): p. 1528-35.
- Herawi M, Epstein JI. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Am J Surg Pathol. 2007. Jun;31(6): p. 889-94.
Supplementary files
